Crunching the numbers for ALMS... Refresh in a moment for the full analysis.
ALUMIS INC. (ALMS)
Healthcare
weak
$23.05
Updated: 2026-04-12
42
TradeApes Score
reduce
Financial Strength
50
Mixed
Operating Trend
30
Weak
Valuation
50
Mixed
Capital Allocation
30
Weak
Risk
50
Mixed
Key Findings
+
Low leverage — net debt/EBITDA below 1×
−
Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.